PubRank

G F Webster

Author PubWeight™ 40.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regional variations of cutaneous propionibacteria. Appl Environ Microbiol 1978 2.00
2 Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983 1.67
3 Pathogenic JK group corynebacteria and their similarity to human cutaneous lipophilic diphtheroids. J Infect Dis 1985 1.38
4 Skin microflora. J Invest Dermatol 1987 1.33
5 Epithelioid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet 1987 1.30
6 Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immun 1985 1.26
7 Regional variations in density of cutaneous propionibacteria: correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol 1980 1.24
8 Use of bacteriophage typing to distinguish Propionibacterium acne types I and II. J Clin Microbiol 1978 1.19
9 Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry. J Clin Microbiol 1980 1.17
10 Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun 1978 1.16
11 Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 1980 1.14
12 Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. J Am Acad Dermatol 2001 1.09
13 Correlation of Propionibacterium acnes populations with the presence of triglycerides on nonhuman skin. Appl Environ Microbiol 1981 1.01
14 Complement activation in acne vulgaris: consumption of complement by comedones. Infect Immun 1979 0.98
15 Use of litmus milk agar for presumptive identification of cutaneous propionibacteria. J Clin Microbiol 1977 0.96
16 Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J Invest Dermatol 1980 0.96
17 Onycholysis associated with weekly administration of paclitaxel. Ann Pharmacother 1999 0.92
18 Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin. Br J Dermatol 1981 0.91
19 Direct interaction of antifungal azole-derivatives with calmodulin: a possible mechanism for their therapeutic activity. J Invest Dermatol 1993 0.90
20 Analysis of cellular components, biochemical reactions, and habitat of human cutaneous lipophilic diphtheroids. J Invest Dermatol 1985 0.90
21 Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions. Inflammation 1981 0.90
22 Facial follicular porphyrin fluorescence: correlation with age and density of Propionibacterium acnes. Br J Dermatol 1980 0.87
23 Acne. A review of optimum treatment. Drugs 1994 0.86
24 Characteristic gamma-lactone odor production of the genus Pityrosporum. Appl Environ Microbiol 1979 0.85
25 Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin. Antimicrob Agents Chemother 1982 0.84
26 The effect of the menstrual cycle on acne. J Am Acad Dermatol 2001 0.83
27 Intralesional fluorouracil/epinephrine injectable gel for treatment of condylomata acuminata. A phase 3 clinical study. Arch Dermatol 1997 0.82
28 Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis. Am J Gastroenterol 1993 0.81
29 Vascular diseases are the most common cutaneous manifestations of reflex sympathetic dystrophy. J Am Acad Dermatol 2001 0.80
30 Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients. J Invest Dermatol 1985 0.79
31 Topical retinoids in the treatment of acne vulgaris. Cutis 1999 0.77
32 Anti-inflammatory actions of benzoyl peroxide: effects on the generation of reactive oxygen species by leucocytes and the activity of protein kinase C and calmodulin. Br J Dermatol 1994 0.77
33 Autoimmune bullous disease in a patient with HIV infection. J Am Acad Dermatol 1991 0.77
34 Acne vulgaris: state of the science. Arch Dermatol 1999 0.76
35 Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion. Int J Dermatol 1996 0.76
36 A method for the assay of inflammatory mediators in follicular casts. J Invest Dermatol 1979 0.76
37 The role of surgery in the management of uncommon skin infections. Dermatol Surg 1995 0.76
38 Inhibition of chemiluminescence in human neutrophils by dapsone. Br J Dermatol 1984 0.76
39 Activation of components of the alternative pathway of complement by Propionibacterium acnes cell wall carbohydrate. J Invest Dermatol 1982 0.75
40 Serologic analysis of the extractable carbohydrate antigens of Pityrosporum ovale. Microbios 1980 0.75
41 Is it reasonable for a dermatologist to treat acne? Arch Dermatol 1996 0.75
42 Are porokeratoses an infection? Arch Dermatol 2001 0.75
43 Phototoxicity from benoxaprofen: in vivo and in vitro studies. Photochem Photobiol 1982 0.75
44 Selective calmodulin antagonists fail to inhibit phorbol ester-induced superoxide anion release from human neutrophils: effects of antifungal azole derivatives. Br J Dermatol 1996 0.75
45 Axillary granular parakeratosis: response to isotretinoin. J Am Acad Dermatol 1997 0.75
46 Medical treatment of acne. G Ital Dermatol Venereol 2009 0.75
47 Mycobacterium intracellulare soft tissue infection. J Am Acad Dermatol 1992 0.75
48 Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer. Int Arch Allergy Appl Immunol 1981 0.75
49 Methotrexate therapy in cutaneous sarcoidosis. Ann Intern Med 1989 0.75
50 Pancytopenia following low-dose oral methotrexate therapy for psoriasis. JAMA 1988 0.75
51 Mycocutaneous atypical mycobacterial infections in acquired immunodeficiency syndrome. Clin Dermatol 1996 0.75